Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RCKT
RCKT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RCKT News
Rocket Pharmaceuticals Receives Accelerated FDA Approval for Kresladi
Mar 30 2026
NASDAQ.COM
Rocket Pharmaceuticals Secures FDA Approval for KRESLADI
Mar 29 2026
Yahoo Finance
RCKT Shares Plummet Following Gene Therapy Approval as Wall Street Overlooks Decline
Mar 27 2026
stocktwits
ROCKET PHARMA EXECUTIVE ANNOUNCES ACTIVE TALKS WITH EXTERNAL PARTIES ABOUT SELLING THE PRIORITY REVIEW VOUCHER
Mar 27 2026
moomoo
Rocket Pharmaceuticals Stock Rises 10.2% in Premarket Trading Following FDA Approval of Therapy for Severe Childhood Disorder
Mar 27 2026
moomoo
Rocket Pharmaceuticals Secures Accelerated Approval for KRESLADI Gene Therapy
Mar 27 2026
NASDAQ.COM
FDA Approves First Gene Therapy for Children with Severe LAD-I
Mar 27 2026
Newsfilter
Rocket Pharmaceuticals' Kresladi Receives FDA Approval
Mar 27 2026
seekingalpha
FDA Approves Rocket's Gene Therapy Kresladi for Pediatric Use
Mar 27 2026
stocktwits
Trump Extends Deadline for Potential Strikes on Iran
Mar 27 2026
stocktwits
Nasdaq and S&P 500 Futures Climb as Iran Deadline Postponement Eases Concerns: Key Stocks Keeping Traders Active Today Include NVDA, META, TSLA, RCKT, and CCL
Mar 27 2026
stocktwits
RCKT Stock Surges More Than 10% in Premarket Trading Following FDA Approval of Its First Gene Therapy for Rare Pediatric Immune Disorder
Mar 27 2026
stocktwits
Rocket Pharmaceuticals Q4 Earnings Beat Expectations
Feb 26 2026
seekingalpha
Overview of FDA Regulatory Developments
Feb 25 2026
NASDAQ.COM
Analysts Recommend Rocket Pharmaceuticals as a Top Buy
Feb 19 2026
Yahoo Finance
KBRA Assigns Ratings to $548.3 Million RCKT Mortgage Trust 2026-CES1
Jan 13 2026
Businesswire
Show More News
